Advanced search
Publication Cover
Risk Management and Healthcare Policy Volume 16, 2023 - Issue
Submit an article Journal homepage
194
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Serum NLRC4 as a Potential Prognostic Biochemical Marker in Humans with Severe Traumatic Brain Injury: A Prospective Cohort Study

Bei TangDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
,
Ze ZhongDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Jinping WuDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
,
Jianping MaDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
,
Li LiDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
,
Xuzheng ZhongDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
,
Dongmei LinDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
,
Jiayuan HuDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
&
Pingan YuDepartment of Critical Care Medicine, The First People’s Hospital of Jiande City, Jiande, People’s Republic of ChinaView further author information
 show all
Pages 439-454 | Received 14 Jan 2023, Accepted 15 Mar 2023, Published online: 23 Mar 2023

References

  • Stocchetti N, Carbonara M, Citerio G, et al. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017;16(6):452–464. doi:10.1016/S1474-4422(17)30118-7
  • Geeraerts T, Velly L, Abdennour L, et al. Management of severe traumatic brain injury (first 24hours). Anaesth Crit Care Pain Med. 2018;37(2):171–186. doi:10.1016/j.accpm.2017.12.001
  • Kowalski RG, Hammond FM, Weintraub AH, et al. Recovery of consciousness and functional outcome in moderate and severe traumatic brain injury. JAMA Neurol. 2021;78(5):548–557. doi:10.1001/jamaneurol.2021.0084
  • Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am. 2020;104(2):213–238. doi:10.1016/j.mcna.2019.11.001
  • Rakhit S, Nordness MF, Lombardo SR, Cook M, Smith L, Patel MB. Management and challenges of severe traumatic brain injury. Semin Respir Crit Care Med. 2021;42(1):127–144. doi:10.1055/s-0040-1716493
  • Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18(2):165–180. doi:10.1080/14737159.2018.1428089
  • Posti JP, Tenovuo O. Blood-based biomarkers and traumatic brain injury-A clinical perspective. Acta Neurol Scand. 2022;146(4):389–399. doi:10.1111/ane.13620
  • Sulhan S, Lyon KA, Shapiro LA, Huang JH. Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: pathophysiology and potential therapeutic targets. J Neurosci Res. 2020;98(1):19–28. doi:10.1002/jnr.24331
  • Kursun O, Yemisci M, van den Maagdenberg AMJM, Karatas H. Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain. 2021;22(1):55. doi:10.1186/s10194-021-01271-1
  • Mason DR, Beck PL, Muruve DA. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. J Innate Immun. 2012;4(1):16–30. doi:10.1159/000334247
  • Duncan JA, Canna SW. The NLRC4 Inflammasome. Immunol Rev. 2018;281(1):115–123. doi:10.1111/imr.12607
  • Freeman L, Guo H, David CN, Brickey WJ, Jha S, Ting JP. NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med. 2017;214(5):1351–1370. doi:10.1084/jem.20150237
  • Gan H, Zhang L, Chen H, et al. The pivotal role of the NLRC4 inflammasome in neuroinflammation after intracerebral hemorrhage in rats. Exp Mol Med. 2021;53(11):1807–1818. doi:10.1038/s12276-021-00702-y
  • Poh L, Kang SW, Baik SH, et al. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke. Brain Behav Immun. 2019;75:34–47. doi:10.1016/j.bbi.2018.09.001
  • Yan XJ, Li YB, Liu W, Wu HY, Yu GF. Elevated serum complement C1q levels after traumatic brain injury and its association with poor prognosis. Neuropsychiatr Dis Treat. 2022;18:47–55. doi:10.2147/NDT.S348682
  • Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420. doi:10.1038/nri.2016.58
  • Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi:10.1038/nm.3893
  • Lünemann JD, Malhotra S, Shinohara ML, Montalban X, Comabella M. Targeting Inflammasomes to treat neurological diseases. Ann Neurol. 2021;90(2):177–188. doi:10.1002/ana.26158
  • Sundaram B, Kanneganti TD. Advances in understanding activation and function of the NLRC4 inflammasome. Int J Mol Sci. 2021;22(3):1048. doi:10.3390/ijms22031048
  • Jin P, Qi D, Cui Y, et al. Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage. J Neuroinflammation. 2022;19(1):198. doi:10.1186/s12974-022-02558-z
  • Zhang X, Huang T, Lang L, Yu L. Effects of lysophosphatidic acid receptor 5 on NLRC4 inflammasome in brain tissues of transient cerebral ischemia/reperfusion rat. Hum Exp Toxicol. 2022;41:9603271221078870. doi:10.1177/09603271221078870
  • Habib P, Harms J, Zendedel A, Beyer C, Slowik A. Gonadal hormones E2 and P mitigate cerebral ischemia-induced upregulation of the AIM2 and NLRC4 inflammasomes in rats. Int J Mol Sci. 2020;21(13):4795. doi:10.3390/ijms21134795
  • Ding W, Cai C, Zhu X, Wang J, Jiang Q. Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3/NF-κB and inflammasome activation. Int Immunopharmacol. 2022;108:108913. doi:10.1016/j.intimp.2022.108913

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.